Chou Associates Management’s AstraZeneca AZN Stock Holding History

Chou Associates Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,500	Closed	-$711K	–	28
2016 Q4	$711K	Hold	6,500	–	–	0.23%	26
2016 Q3	$843K	Hold	6,500	–	–	0.31%	23
2016 Q2	$773K	Hold	6,500	–	–	0.3%	24
2016 Q1	$730K	Hold	6,500	–	–	0.24%	22
2015 Q4	$885	Hold	6,500	–	–	0.19%	20
2015 Q3	$822K	Sell	6,500 -6,500	-50%	-$428K	0.28%	21
2015 Q2	$822K	Hold	13,000	–	–	0.25%	20
2015 Q1	$893K	Hold	13,000	–	–	0.23%	21
2014 Q4	$923K	Hold	13,000	–	–	0.24%	20
2014 Q3	$1.7M	Hold	13,000	–	–	0.43%	18
2014 Q2	$1.03M	Hold	13,000	–	–	0.28%	16
2014 Q1	$840K	Hold	13,000	–	–	0.23%	17
2013 Q4	$766K	Buy	+13,000	New	+$706K	0.22%	18

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Chou Associates Management's AZN Position: Q1 2017 in Review

Chou Associates Management sold out of AstraZeneca (AZN) in Q1 2017, closing a stake of 6,500 shares — an estimated $711K sold.

Chou Associates Management first reported a position in AZN in Q4 2013 and held it in 13 quarters. The position peaked at $1.7M in Q3 2014. 461 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

Chou Associates Management reported no remaining AstraZeneca position as of Q1 2017 after selling out during the quarter.
Chou Associates Management sold 6,500 AstraZeneca shares in Q1 2017, an estimated $711K.
Chou Associates Management first reported a position in AstraZeneca in Q4 2013 and held it in 13 quarters.
Chou Associates Management's AstraZeneca position peaked at $1.7M in Q3 2014.
461 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on Chou Associates Management's 13F filing for Q1 2017, filed 12 May 2017.